Aspira Pathlab
59.35
+1.15(+1.98%)
Market Cap₹61.08 Cr
PE Ratio24.98
Company Performance:
1D+1.98%
1M+5.31%
6M-7.41%
1Y-5.16%
5Y+98.49%
View Company Insightsright
More news about Aspira Pathlab
10Feb 26
Aspira Pathlab Reports Q3FY26 Net Loss of ₹156.12 Lakhs Against Prior Year Profit
Aspira Pathlab & Diagnostics Limited reported a net loss of ₹156.12 lakhs for Q3FY26 against a profit of ₹37.66 lakhs in Q3FY25, with revenue declining 5.33% to ₹511.88 lakhs. For nine months FY26, the company maintained profitability at ₹74.03 lakhs despite a 45.17% decline from ₹135.02 lakhs in the previous year. The Board approved a ₹5 crore related party transaction with Yashraj Research Foundation subject to member approval.
 no imag found
07Jan 26
Aspira Pathlab Submits Quarterly Compliance Certificate for Q3FY26 Under SEBI Regulations
Aspira Pathlab & Diagnostics Limited has submitted its compliance certificate under SEBI Regulation 74(5) for Q3FY26 quarter ended December 31, 2025. The certificate, issued by registrar MUFG Intime India Private Limited, confirms proper handling of securities dematerialisation processes and adherence to prescribed timelines for regulatory compliance.
 no imag found
02Jan 26
Aspira Pathlab & Diagnostics Limited Announces Demise of Independent Director Dr. Alaka Keshav Deshpande
Aspira Pathlab & Diagnostics Limited announced the death of Independent Director Dr. Alaka Keshav Deshpande on December 30, 2025, at age 79. Her demise results in cessation of her directorship and memberships in the Audit Committee, Nomination & Remuneration Committee, and Stakeholder Relationship Committee. The company described her loss as irreparable and has conveyed condolences to her family while fulfilling regulatory disclosure requirements under SEBI LODR Regulations.
 no imag found
13Nov 25
Aspira Pathlab Reports Q2 Loss, Appoints New Independent Director
Aspira Pathlab Diagnostics Limited reported a net loss of ₹230.49 lakhs for the quarter ended September 30, compared to a profit of ₹97.36 lakhs in the same period last year. The company appointed Mrs. Kiran Raghavendra Awasthi as an Additional Independent Director for a five-year term, effective November 12. Aspira Pathlab also acquired the business undertaking of Aspira DNA Diagnostics Gujarat LLP for ₹13.00 lakhs, effective June 30.
 no imag found
26Sept 25
Aspira Pathlab & Diagnostics Receives Open Offer for 26% Stake at Rs. 55 Per Share
Five acquirers and a person acting in concert have announced an open offer to acquire 26.00% (26,76,180 equity shares) of Aspira Pathlab & Diagnostics Limited at Rs. 55.00 per share. The offer, announced on September 26, 2025, complies with SEBI regulations. Aspira, established in 1973, reported a profit of Rs. 2.07 crores in FY 2024-25, a turnaround from previous year's loss. The company has over 600 centers across India and added 91 new locations in the last fiscal year.
 no imag found
Aspira Pathlab
59.35
+1.15
(+1.98%)
1 Year Returns:-5.16%
Industry Peers
Dr. Lal Path Labs
1,402.10
(-0.62%)
Vijaya Diagnostic Centre
1,022.55
(+0.33%)
Metropolis Healthcare
471.70
(-0.12%)
Krsnaa Diagnostics
622.75
(+1.01%)
Suraksha Diagnostic
282.57
(+0.24%)
3B BlackBio DX
1,315.00
(+5.51%)
Sastasundar Ventures
269.15
(-0.26%)